AU1258699A - Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation - Google Patents

Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation

Info

Publication number
AU1258699A
AU1258699A AU12586/99A AU1258699A AU1258699A AU 1258699 A AU1258699 A AU 1258699A AU 12586/99 A AU12586/99 A AU 12586/99A AU 1258699 A AU1258699 A AU 1258699A AU 1258699 A AU1258699 A AU 1258699A
Authority
AU
Australia
Prior art keywords
propionylcarnitine
medicament
manufacture
cell proliferation
smooth muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12586/99A
Inventor
Menotti Calvani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU1258699A publication Critical patent/AU1258699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU12586/99A 1998-11-11 1998-11-11 Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation Abandoned AU1258699A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1998/000318 WO2000027386A1 (en) 1998-11-11 1998-11-11 Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
AU1258699A true AU1258699A (en) 2000-05-29

Family

ID=11332914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12586/99A Abandoned AU1258699A (en) 1998-11-11 1998-11-11 Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation

Country Status (2)

Country Link
AU (1) AU1258699A (en)
WO (1) WO2000027386A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061341A1 (en) * 2004-12-10 2006-06-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of propionyl l-carnitine for the preparation of a high-dose medicament for the treatment of peripheral arterial disease
CN101278928B (en) * 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 Medicament composition containing levocarnitine or its derivatives and use thereof
ES2306610B1 (en) * 2007-04-16 2009-09-11 Universidad De Sevilla USE OF L-CARNITINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION.
ES2351753B1 (en) * 2009-07-07 2011-09-29 Universidad De Sevilla USE OF L-CARNITINE FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY CARDIAC DAMAGE ASSOCIATED WITH ARTERIAL HYPERTENSION.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206954B (en) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti THERAPEUTIC AGENTS BASED ON AN ACIL DERIVATIVE OF CARNITINE FOR THE TREATMENT OF PERIPHERAL VASCULOPATHIES
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US5786326A (en) * 1995-02-03 1998-07-28 Horwitz; Lawrence D. Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
PT793962E (en) * 1996-03-04 2000-05-31 Sigma Tau Ind Farmaceuti A drug containing a carnitine derivative for the treatment of arteriosclerosis obliterans

Also Published As

Publication number Publication date
WO2000027386A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
IL144668A (en) Use of a 4-h-1-benzopyran-4-one derivative for the preparation of a medicament for inhibiting smooth muscle cell proliferation
AU1260401A (en) Thumb splint
AU5259100A (en) Medicament
AU4065800A (en) Intraluminal lining
AU5760900A (en) Multiple agent diabetes therapy
AU4210599A (en) Electronic pillbox for administering a multiple-drug therapy
IL150053A0 (en) Pharmaceutical superdisintegrant
AU8495998A (en) Improved dosage units
AU1986099A (en) Device for inhaling medicament
EP1158314A4 (en) Matlike high-transmittance film
EE03851B1 (en) Use of amines for the manufacture of a medicament for inhibiting the proliferation of tumor cells
AU1151300A (en) Medicament transferring device
AU6043600A (en) Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications
AU1645700A (en) Oenothein medicaments
AU1258699A (en) Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation
AU6309999A (en) Therapeutic ankle orthosis
AU5434599A (en) Exerciser
AU2001233064A1 (en) Methods for inhibiting smooth muscle cell proliferation
AU6735100A (en) Abdominal exerciser
AU9321198A (en) Dosage forms having improved release properties
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU1752101A (en) Medicament cartridge
AU6878198A (en) Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
GB9827865D0 (en) Medicament

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase